Sepsis Management Guidelines
Administer IV antimicrobials within 60 minutes of recognizing sepsis or septic shock—this is the single most critical intervention for reducing mortality. 1, 2
Immediate Recognition and Initial Actions (First Hour)
Time-critical interventions must occur simultaneously:
Obtain blood cultures immediately (at least two sets: one percutaneous, one through each vascular access device if present), but never delay antimicrobials beyond 45 minutes waiting for cultures 1, 2
Measure serum lactate as a marker of tissue hypoperfusion to guide resuscitation 1, 2
Administer 30 mL/kg IV crystalloid fluids within 3 hours for sepsis-induced hypoperfusion (hypotension or lactate ≥4 mmol/L) 1, 2
Start broad-spectrum antimicrobials within 60 minutes—mortality risk increases 8% for each hour of delay 3, 4
Antimicrobial Therapy Strategy
Empiric antibiotic selection:
Use broad-spectrum therapy covering all likely pathogens (bacterial, fungal, viral) based on the presumed infection source, patient risk factors, and local resistance patterns 1, 2
Consider combination therapy (≥2 antibiotics from different classes) for:
Ensure adequate tissue penetration to the presumed infection source when selecting agents 1, 2
De-escalation strategy:
Reassess antimicrobial therapy daily for potential narrowing once pathogen identification and sensitivities are available 1, 2
Limit combination therapy to 3-5 days maximum, then de-escalate to single-agent therapy 2, 5
Consider longer courses only for slow clinical response, undrainable foci, S. aureus bacteremia, fungal/viral infections, or immunodeficiency 2
Use procalcitonin levels to assist in discontinuing empiric antibiotics in patients without subsequent evidence of infection 2
Hemodynamic Resuscitation
Vasopressor management:
Target mean arterial pressure (MAP) ≥65 mmHg in patients requiring vasopressors 1, 2
Use norepinephrine as first-choice vasopressor 1
Fluid management:
After initial 30 mL/kg crystalloid bolus, guide additional fluids by frequent reassessment of hemodynamic status using thorough clinical examination 1, 2
Normalize lactate in patients with elevated levels as a resuscitation endpoint 2
Source Control
Implement source control interventions as soon as possible after diagnosis:
Perform imaging studies promptly to confirm the infection source 1, 2
Remove potentially infected foreign bodies or devices (catheters, prosthetics) 1, 2
Respiratory Support
Oxygenation and ventilation strategy:
Position patients semi-recumbent (head of bed 30-45°) to reduce aspiration risk 1, 2
Use low tidal volume ventilation (6 mL/kg predicted body weight) for sepsis-induced ARDS 1, 2
Metabolic and Supportive Care
Glucose management:
Transfusion strategy:
- Target hemoglobin 7-9 g/dL in the absence of tissue hypoperfusion, coronary disease, or acute hemorrhage 1, 2
Sedation:
Nutritional Support
Enteral feeding approach:
Initiate early enteral feeding rather than complete fasting or IV glucose only in patients who can be fed enterally 2
Use either early trophic/hypocaloric or early full enteral feeding; advance feeds according to patient tolerance if starting with trophic feeding 2
Use prokinetic agents for feeding intolerance 2
Place post-pyloric feeding tubes in patients with feeding intolerance or high aspiration risk 2
Avoid omega-3 fatty acids as immune supplements, IV selenium, arginine, and glutamine supplementation 2
Performance Improvement and Systems
Hospital-wide implementation:
Implement sepsis screening programs for acutely ill, high-risk patients 1, 2
Establish multidisciplinary teams including physicians, nurses, pharmacy, and respiratory therapy 1, 2
Use sepsis bundles and protocols with regular education and performance feedback 1, 2
Goals of Care
Communication with patients and families:
Discuss goals of care and prognosis with patients and families, ideally within 72 hours of ICU admission 1, 2
Incorporate palliative care principles into treatment planning when appropriate 1, 2
Common Pitfalls to Avoid
Never delay antimicrobials waiting for diagnostic studies—the 60-minute window is critical for mortality reduction 1, 2, 4
Avoid standard dosing approaches—individualized dosing based on pharmacokinetics/pharmacodynamics and organ dysfunction is essential 3
Do not continue combination therapy beyond 3-5 days without clear justification—this drives resistance 2, 5
Avoid prolonged antibiotic courses without specific indications—7-10 days is sufficient for most patients 2, 5